Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × tucatinib × Clear all

Phase

Status

Recruiting 16 Completed 10 Active not recruiting 8 Withdrawn 5 Terminated 4 Not yet recruiting 3 Unknown 1 Suspended 1 No longer available 1 Approved for marketing 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 1

Interventions

Specimen Handling 31 Magnetic Resonance Spectroscopy 21 Biopsy 16 Cyclophosphamide 14 Paclitaxel 8 Nivolumab 8 Bevacizumab 8 Gemcitabine 7 Cisplatin 7 pembrolizumab 6 Docetaxel 6 Vincristine 5 Radiotherapy 5 Radiosurgery 5 Prednisone 5 Fluorouracil 5 Doxorubicin 5 Carboplatin 5 Capecitabine 5 fludarabine 4 atezolizumab 4 Rituximab 4 Radiation 4 Oxaliplatin 4 Lenalidomide 4 Ipilimumab 4 Etoposide 4 Drug Therapy 4 Azacitidine 4 venetoclax 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05062889 2026-02-03

ERASE-CRC

Gruppo Oncologico del Nord-Ovest

Phase 2 Suspended

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡